| Dr Michael Paul Watson, MD | |
|
1603 Terral Island Rd, Farmerville, LA 71241-4012 | |
| (318) 368-4393 | |
| Not Available |
| Full Name | Dr Michael Paul Watson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 50 Years |
| Location | 1603 Terral Island Rd, Farmerville, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245429471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | MD.012676 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Medical Center | Monroe, LA | Hospital |
| Monroe Surgical Hospital | Monroe, LA | Hospital |
| Glenwood Regional Medical Center | West monroe, LA | Hospital |
| Entity Name | M. Paul Watson, M.d. A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487822946 PECOS PAC ID: 6002990751 Enrollment ID: O20080220000186 |
News Archive
40 percent of people in the EU suffer from non-alcoholic steatohepatitis (fatty liver disease), a disease which is becoming increasingly more frequent as a result of diabetes and excess weight in an affluent society. Currently, it is not possible to forecast the further course of the disease - right up to cirrhosis and cancer of the liver. Furthermore, an increased risk of heart attack and kidney damage exists. In future, this should become possible using a Risk Score with different biomarkers.
Kylene Kehn-Hall, Associate Professor/Associate Director, School of Systems Biology, National Center for Biodefense and Infectious Diseases, is working to rapidly test and deploy a universal virus enrichment tool that can be used to enhance the detection of SARS-CoV-2 (COVID-19) for any type of diagnostic assay under development, thereby reducing false negatives and the risk of worldwide pandemic.
Approximately one-third of all high-tech imaging performed in the United States proves medically unnecessary. Specialty benefits management provider HealthHelp announced today the launch of a new program designed to reduce unnecessary radiation exposure and to promote cost-effective treatment planning for the best possible outcome.
It has been well documented that smoking during pregnancy can harm the developing baby, but now, according to researchers, women who smoke during pregnancy may increase the risk of their child displaying anti-social behaviour.
Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Paul Watson, MD 1603 Terral Island Rd, Farmerville, LA 71241-4012 Ph: (318) 368-4393 | Dr Michael Paul Watson, MD 1603 Terral Island Rd, Farmerville, LA 71241-4012 Ph: (318) 368-4393 |
News Archive
40 percent of people in the EU suffer from non-alcoholic steatohepatitis (fatty liver disease), a disease which is becoming increasingly more frequent as a result of diabetes and excess weight in an affluent society. Currently, it is not possible to forecast the further course of the disease - right up to cirrhosis and cancer of the liver. Furthermore, an increased risk of heart attack and kidney damage exists. In future, this should become possible using a Risk Score with different biomarkers.
Kylene Kehn-Hall, Associate Professor/Associate Director, School of Systems Biology, National Center for Biodefense and Infectious Diseases, is working to rapidly test and deploy a universal virus enrichment tool that can be used to enhance the detection of SARS-CoV-2 (COVID-19) for any type of diagnostic assay under development, thereby reducing false negatives and the risk of worldwide pandemic.
Approximately one-third of all high-tech imaging performed in the United States proves medically unnecessary. Specialty benefits management provider HealthHelp announced today the launch of a new program designed to reduce unnecessary radiation exposure and to promote cost-effective treatment planning for the best possible outcome.
It has been well documented that smoking during pregnancy can harm the developing baby, but now, according to researchers, women who smoke during pregnancy may increase the risk of their child displaying anti-social behaviour.
Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.
› Verified 2 days ago